Stocks to sell

Some Chinese stocks have generated the occasional pop, but the risk-reward is skewed bearishly. Alibaba (BABA): China’s flagship has been plunging for the better part of the trailing year. JD.com (JD): JD.com is now reflecting consumer weaknesses pinged earlier this year. Ping An Insurance (PNGAY): Ping An is a worryingly exposed company, especially for an
0 Comments
Late last month, virtual healthcare company Teladoc Health (TDOC) experienced a post-earnings plunge. Despite the big drop, a recovery will prove difficult. With the prognosis unchanged, though, steer clear of TDOC stock. Source: Postmodern Studio / Shutterstock.com Like many pandemic-era favorites, the situation has gone from bad to worse when it comes to shares of
0 Comments
Several SPAC mergers could be abandoned this year, with these three at particular risk. Riley Principal 150 Merger Corp (NASDAQ:BRPM): FaZe Clan’s poor liquidity and missed targets could make investors develop cold feet as the SPAC merger deal progresses. Digital World Acquisition Corp (NASDAQ:DWAC): Former President Donald Trump-related Truth Social platform’s launch faced challenges, regulatory
0 Comments
Novavax (NASDAQ:NVAX) was so close to hitting gold, but the delay in FDA approval for its Covid-19 vaccine has taken the life out of this stock, leaving a lot of investors wondering — what’s next? After reporting its first-quarter results, NVAX stock dipped 20% and hit $43. Despite making the right moves and filing for
0 Comments
The enthusiastic remarks of AMC (NYSE:AMC) Chief Executive Officer (CEO) Adam Aron after the company’s better-than-expected first-quarter results seemed misplaced. His comments reminded me of sports teams that had a horrible win-lose record and are losing by a wide margin in a game they’re currently playing, but celebrate one good play they made as if
0 Comments
With Twitter (NYSE:TWTR) and TWTR stock facing multiple, tough threats and possessing no major positive catalysts, I recommend that investors sell the shares. Overall, the biggest threat facing Twitter and its shares is the possibility that the takeover of the company — led by Tesla (NASDAQ:TSLA) CEO Elon Musk — will not close. Such an outcome
0 Comments
Nio (NIO) offers Tesla (TSLA) luxury without the production volumes. The company has stiff competition within China, and those competitors are now exporting. Nio will likely remain small, and investors should demand a profit. Source: Robert Way / Shutterstock.com At this point in the game, investing in Nio (NYSE:NIO) stock means investing in the Chinese
0 Comments
According to short-seller Hindenburg research, Mullen Automotive (NASDAQ:MULN) may be the next electric vehicle stock debacle. The news that Hindenburg Research has Mullen Automotive in its sights is not new. The short seller revealed its findings over a month ago. But those findings are worth revisiting as the stock continues to behave with volatility. Further,
0 Comments
Medical health services company Teladoc Health (NYSE:TDOC) has seen its prognosis go from bad to worse over the past month. TDOC stock had already plunged as part of the broader selloff in speculative technology companies. However, that selloff accelerated dramatically following Teladoc’s latest earnings report, which was a disappointment on almost all fronts. The terrible
0 Comments
Affirm (NASDAQ:AFRM) continues to fly multiple red flags, including a high valuation, very tough competition and a bottom line that may be deteriorating. Additionally, there are multiple signs that the Street is quite bearish on the shares. In light of all of these points, I continue to recommend investors sell AFRM stock. The trailing price-to-sales
0 Comments